Evidence map›Paper›PMID 25028937›Full record

ArticlePloS one2014

Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.

Hongshuo Song, Bhavna Hora, Tanmoy Bhattacharya, Nilu Goonetilleke, Michael K P Liu, Kevin Wiehe, Hui Li, Shilpa S Iyer, Andrew J McMichael, Alan S Perelson and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hongshuo SongDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Bhavna HoraDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Tanmoy BhattacharyaTheoretical Division, Los Alamos National laboratory, Los Alamos, New Mexico, United States of America; Santa Fe Institute, Santa Fe, New Mexico, United States of America.
Nilu GoonetillekeWeatherall Institute of molecular Medicine, University of Oxford, Oxford, England, United Kingdom.
Michael K P LiuWeatherall Institute of molecular Medicine, University of Oxford, Oxford, England, United Kingdom.
Kevin WieheDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Hui LiDepartments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Shilpa S IyerDepartments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Andrew J McMichaelWeatherall Institute of molecular Medicine, University of Oxford, Oxford, England, United Kingdom.
Alan S PerelsonTheoretical Division, Los Alamos National laboratory, Los Alamos, New Mexico, United States of America.
Feng GaoDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · USUniversity of Oxford · GBLos Alamos National Laboratory · USUniversity of Pennsylvania · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI LETVIN, NORMAN L · 2006 to 2011
$290.5M
Virus biology scientific research support componentUM1AI100645 · NIAID · DUKE UNIVERSITY · PI MCMICHAEL, ANDREW JAMES · 2012 to 2018
$204.7M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
Modeling Viral and T Lymphocyte DynamicsR01OD011095 · OD · TRIAD NATIONAL SECURITY, LLC · PI PERELSON, ALAN S · 2012 to 2024
$5.0M
Immune System Modeling/HIVR01AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1990 to 2021
$3.7M
Immune System Modeling/HIVR37AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 2002 to 2011
$2.4M
Medical Research Council MR/K012037/1NIAID NIH HHS AI028433NIAID NIH HHS AI064518NIAID NIH HHS AI067854NIAID NIH HHS AI100645NIAID NIH HHS P30 AI064518NIAID NIH HHS R01 AI028433NIAID NIH HHS R37 AI028433NIAID NIH HHS U01 AI067854NIAID NIH HHS U19 AI067854NIAID NIH HHS UM1 AI100645NIH HHS OD011095NIH HHS R01 OD011095
6 · The paper itself

Abstract

Immune escape mutations that revert back to the consensus sequence frequently occur in newly HIV-1-infected individuals and have been thought to render the viruses more fit. However, their impact on viral fitness and their interaction with other immune escape mutations have not been evaluated in the background of their cognate transmitted/founder (T/F) viral genomes. To precisely determine the role of reversion mutations, we introduced reversion mutations alone or together with CD8+ T cell escape mutations in their unmodified cognate T/F viral genome and determined their impact on viral fitness in primary CD4+ T cells. Two reversion mutations, V247I and I64T, were identified in Gag and Tat, respectively, but neither had measurable effect on the fitness of their cognate T/F virus. The V247I and G248A mutations that were detected before and concurrently with the potent T cell escape mutation T242N, respectively, were selected by early T cell responses. The V247I or the G248A mutation alone partially restored the fitness loss caused by the T242N mutation. Together they could fully restore the fitness of the T242N mutant to the T/F level. These results demonstrate that the fitness loss caused by a T cell escape mutation could be compensated by preexisting or concurrent reversion and other T cell escape mutations. Our findings indicate that the overall viral fitness is modulated by the complex interplay among T cell escape, compensatory and reversion mutations to maintain the balance between immune escape and viral replication capacity.

Indexed as

Base SequenceCD8-Positive T-LymphocytesDNA PrimersEnzyme-Linked Immunospot AssayGenetic FitnessGenome, ViralHIV-1HumansImmune EvasionMolecular Sequence DataMutation, MissenseSequence Analysis, DNAVirus ReplicationDNA Primers

Identifiers

PMID25028937
PMCPMC4100905
OpenAlexW2004386997

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.